IP Library Granted Patent US 10,844,430
Granted Patent B2
US 10,844,430 · App. 15/878,633 · Granted Nov 24, 2020

DNA sequencing reaction additive

Inventors: Luisa Andruzzi (Concord, MA); Jimmy Adediran (Waltham, MA); Timothy Pelletier (Leominster, MA); Austin Ricker (Waltham, MA); Angela DeLucia (Cambridge, MA); Ben McNally (Medford, MA); Dona Hevroni (Lexington, MA); Mong Sano Marma (Natick, MA); John Andrew Sheridan (Marblehead, MA)
Assignee: Qiagen Sciences, LLC
C12Q1/6869C12Q1/6806C12Q1/6876C07D275/03C12Q2525/113C12Q2525/186C12Q2600/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,844,430
App. No.
15/878,633
Granted
Nov 24, 2020
Kind
B2
Abstract

The present invention provides methods, compositions, mixtures and kits utilizing 5-Chloro-2-methyl-4-isothiazolin-3-one in sequencing reactions, and in particular, sequencing reactions where deoxynucleoside triphosphates comprising a 3′-O position capped by a disulfide-based 3′-terminator group are used. In one embodiment, the deoxynucleoside triphosphates comprise a 3′-O position capped by a group comprising methylenedisulfide as a cleavable protecting group and a detectable label reversibly connected to the nucleobase of said deoxynucleoside. In addition, thiol-containing compounds and scavengers of thio-containing compounds are described. Such compounds provide new possibilities for future sequencing technologies, including but not limited to Sequencing by Synthesis.

Claims (31)

1. A method of incorporating nucleotides, comprising:

a) providing i) a plurality of nucleic acid primers and template molecules, and ii) an extend reagent comprising polymerase, a plurality of nucleotide analogues, wherein said nucleotide analogues comprise a 3′-O position capped by a disulfide-based 3′-terminator group and a label attached through a cleavable disulfide linker to the base, and 5-Chloro-2-methyl-4-isothiazolin-3-one;

b) hybridizing at least a portion of said primers to at least a portion of said template molecules so as to create hybridized primers; and

c) exposing said hybridized primers to said extend reagent in an extension reaction under conditions such that a first nucleotide analogue is incorporated into at least a portion of said hybridized primers so as to create extended primers comprising an incorporated nucleotide analogue, wherein 5-Chloro-2-methyl-4-isothiazolin-3-one inhibits cleavage of said disulfide-based 3′-terminator group during said extension reaction.

2. The method of claim 1 , wherein said disulfide-based 3′-terminator group comprises methylenedisulfide as a cleavable protecting group.

3. The method of claim 1 , wherein said extend reagent further comprises 2-Methyl-4-isothiazolin-3-one.

4. The method of claim 1 , further comprising:

d) detecting said label of a first labeled nucleotide analogue.

5. The method of claim 4 , further comprising:

e) cleaving said linker with a cleaving reagent so as to remove said label.

6. The method of claim 5 , wherein cleaving reagent also removes said disulfide-based 3′-terminator group.

7. The method of claim 6 , wherein said cleaving reagent is a thiol-containing compound.

8. The method of claim 7 , wherein the thiol-containing compound is a vicinal dithiol-based compound.

9. The method of claim 4 , wherein the vicinal dithiol-based compound is di-mercaptopropanesulfonate.

10. A method for detecting labeled nucleotides in a nucleic acid sequence comprising the steps of

a) providing i) nucleic acid template and primer capable of hybridizing to said template so as to form a primer/template hybridization complex, ii) an extend reagent comprising polymerase, a plurality of nucleotide analogues, and 5-Chloro-2-methyl-4-isothiazolin-3-one, wherein said nucleotide analogues comprise a nucleobase and a sugar, said sugar comprising a cleavable protecting group on the 3′-O, wherein said cleavable protecting group comprises a disulfide-based 3′-terminator group, and wherein at least a portion of said nucleotide analogues further comprises a first detectable label attached via a cleavable disulfide-containing linker to the nucleobase; and iii) a cleave reagent comprising a thiol-containing compound;

b) hybridizing at least a portion of said primers to at least a portion of said template molecules so as to create hybridized primers; and

c) exposing said hybridized primers to said extend reagent in an extension reaction under conditions such that a first nucleotide analogue comprising a first detectable label is incorporated into at least a portion of said hybridized primers in a polymerase catalyzed primer extension reaction so as to create extended primers comprising an incorporated nucleotide analogue in a modified primer/template hybridization complex, wherein 5-Chloro-2-methyl-4-isothiazolin-3-one inhibits cleavage of said disulfide-based 3′-terminator group during the extension reaction;

d) detecting said first detectable label of said deoxynucleoside triphosphate in said modified primer/template hybridization complex; and

e) introducing said cleave reagent under conditions so as to remove said cleavable protecting group and said detectable label from said modified primer/template hybridization complex.

11. The method of claim 10 , wherein the method further comprises incorporating a second nucleotide analogue comprising a second detectable label during a repeat of step c).

12. The method of claim 10 , wherein the thiol-containing compound is a vicinal dithiol-based compound.

13. The method of claim 12 , wherein the vicinal dithiol-based compound is di-mercaptopropanesulfonate.

14. The method of claim 11 , wherein the nucleobase of said second nucleotide analogue is different from the nucleobase of said first nucleotide analogue.

15. The method of claim 10 , wherein said extend reagent comprises a mixture of at least 4 differently labeled nucleotide analogues representing analogs of A, G, C and T or U.

16. The method of claim 10 , wherein said detecting allows for the determination of the nucleobase of said incorporated first nucleotide analogue.

17. The method of claim 10 , wherein said disulfide-based 3′-terminator group comprises methylenedisulfide as a cleavable protecting group.

18. The method of claim 10 , wherein said extend reagent further comprises 2-Methyl-4-isothiazolin-3-one.

19. The method of claim 10 , further comprising:

f) introducing a scavenger that interacts with the cleave reagent.

20. The method of claim 19 , wherein said scavenger is cystamine.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Mar 24, 2023
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: ISOPLEXIS CORPORATION
Reel/Frame 063235/0942 →
PATENT PURCHASE AGREEMENT Recorded Jul 30, 2021
From: QIAGEN SCIENCES, LLC
To: ISOPLEXIS CORPORATION
Reel/Frame 057043/0629 →
SECURITY AGREEMENT Recorded May 28, 2021
From: ISOPLEXIS CORPORATION
To: PERCEPTIVE CREDIT HOLDINGS III, LP
Reel/Frame 056421/0929 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 19, 2018
From: ANDRUZZI, LUISA; MCNALLY, BEN; DELUCIA, ANGELA; HEVRONI, DONA; ADEDIRAN, JIMMY; PELLETIER, TIMOTHY; RICKER, AUSTIN; MARMA, MONG SANO; SHERIDAN, JOHN ANDREW
To: QIAGEN SCIENCES, LLC
Reel/Frame 046912/0411 →
Continuity (1)
Related Publication 20190226018A1 · Jul 25, 2019